[Evaluation of fraxiparine efficacy in the treatment of retinal vein occlusion].
OBJECTIVE
To evaluate the efficacy of Fraxiparine in the treatment of central retinal vein occlusion and retinal branch vein occlusion.


METHODS
30 patients were treated. Fraxiparine (Sanofi-Pharma) was injected subcutaneously in doses of 7.5 thousand units twice daily for 10 days and once daily for 18 days. In 19 cases central retinal vein occlusion was observed and retinal branch vein occlusion in 11 cases. Mean follow-up was 15 months (range 10-35 months). Ophthalmological examination including fluorescein angiography was performed before and after therapy.


RESULTS
Improvement of visual function and condition of retina after therapy was observed in about 50% of cases. In 16 patients laser photocoagulation applied for neovascularisation or retinal edema was necessary.
Romanowska
B
B
Katedry i Kliniki Okulistyki Collegium Medicum UJ w Krakowie.
Goszcz
A
A
Grodzińska
L
L
Bieroń
K
K
Kostka-Trabka
E
E
D000328:Adult; D000368:Aged; D000792:Angiography / Q000379:methods; D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017762:Nadroparin / Q000627:therapeutic use*; D012170:Retinal Vein Occlusion / Q000000981:diagnostic imaging / Q000188:drug therapy*; D012189:Retrospective Studies; D016896:Treatment Outcome
D000925:Anticoagulants; D017762:Nadroparin